| Stm130Sur-01
| 1. Gastroesophageal junctional carcinoma, 65 cases.
2. Survival information available, being followed up for 3.5-7 years.
| 1.5mm
| USBiolab
|
|
|
|
| € 840,00
|
| LugA150Sur-01
| 1. Lung adenocarcinoma (75 cases), tumor (1 core/dase) and matched normal adjacent tissue (1 core/case).
2. Survival information available. Being followed up for more than 5 years.
3. With IHC data of VEGF and survivin.
| 1.5mm
| USBiolab
|
|
|
|
| € 985,00
|
| MorgH090-01
| 1. Multiple organ (29 types) from aborted fetus (5 cases). 1-5 cases/organ, 1 core/case.
2. Esophagus, stomach, duodenum, jejunum, ileum, liver, pancreas, lung, heart, aorta, ovary, testis, adrenal, kidney, bladder, ureter, pituitary, cerebrum, hippocam
| 2.0mm
| USBiolab
|
|
|
|
| € 503,00
|
| Eso127-01
| 1. Esophagus squamous cell carcinoma (50 cases), 27 cases have tumor(1 core/case) and matched normal adjacent tissue (1 core/case) and negative/positive lymph node (1 core/case), 23 cases have tumor tissue (1 core/case) and positive lymph node (1 core/cas
| 1.5mm
| USBiolab
|
|
|
|
| € 400,00
|
| Liv01-002
| 1. Liver carcinoma (80 cases), 2 cores/case. Normal adjacent tissue (10 cases), 2 cores/case. Other tumor tissue (20 cases), 1 core/case.
2. Pathology grade 1, 2, 3.
| 1.0mm
| USBiolab
|
|
|
|
| € 255,00
|
| Kid02-003
| 1. Kidney clear cell carcinoma (32 cases), 1 core/case.
2. Pathology grade 2-3, 3.
| 2.0mm
| USBiolab
|
|
|
|
| € 156,00
|
| Lug02-003
| 1. Lung squamous cell carcinoma (32 cases), 1 core/case.
2. Pathology grade 2-3, 3.
| 2.0mm
| USBiolab
|
|
|
|
| € 156,00
|
| Liv02-003
| 1. Hepatocellular carcinoma (32 cases), 1 core/case.
2. Pathology grade 2-3, 3.
| 2.0mm
| USBiolab
|
|
|
|
| € 156,00
|
| Pan180Sur-01
| 1. Pancreatic adenocarcinoma (90 cases), tumor (1 core/case) and matched normal adjacent tissue (1 core/case). Clinical stage I, II, IV (Version 7.0).
2. Survival information available. Being followed up for 3-7 years.
3. Smoking history, drinking histo
| 1.5mm
| USBiolab
|
|
|
|
| € 1.571,00
|
| Liv01-008
| 1. Hepatocellular carcinoma (100 cases, pathology grade I, II, III).
2. Sclerosing hepatocellular carcinoma (5 cases)
3. Liver cirrhosis (20 cases)
4. 3 cores/case.
| 1.0mm
| USBiolab
|
|
|
|
| € 372,00
|
| Eso4-007
| 1. Esophagus squamous cell carcinoma (45 cases), 2 cores/case.
2. Pathology grade 1, 1-2, 2, 2-3, 3.
| 2.0mm
| USBiolab
|
|
|
|
| € 241,00
|
| Rau120Sur-01
| 1. Kidney pelivis carcinoma and ureter carcinoma, 120cases. Tumor, 1 core/case
2. Survival information available. Being followed up for 0.5-7 years.
| 1.5mm
| USBiolab
|
|
|
|
| € 840,00
|
| Rec02-002
| 1. Rectum adenocarcinoma (32 cases), 1 core/case.
2. Pathology grade 2.
| 2.0mm
| USBiolab
|
|
|
|
| € 156,00
|
| Eso03-003
| 1. Esophagus carcinoma (21 cases), containing squamous cell carcinoma (9 cases), adenocarcinoma (5 cases), small cell carcinoma ( 6 cases) and undifferentiated carcinoma (1 case). Esophagogastric junction carcinoma (8 cases). Gastric carcinoma (2 cases
| 2.0mm
| USBiolab
|
|
|
|
| € 241,00
|
| ColM060CS-01
| 30 cases of mucous adenocarcinoma of colon /normal adjacent tissue, 1 core/case.Clinical stage I-IV.
| 2.0mm
| USBiolab
|
|
|
|
| € 286,00
|
| Stm150CS-01
| 1. Early stomach adenocarcinoma, 75 cases. Tumor and normal adjacent tissue. 2 cores/case.
2. Clinical Stage I. 29 cases of T1N0M0, 5 cass of T1N1M0, 41 cases of T2N0M0.
| 1.5mm
| USBiolab
|
|
|
|
| € 695,00
|
| Liv04-001
| 1. Hepatocellular carcinoma (41 cases), tumor (1 core/case) and matched normal adjacent tissue (1 core/case).
2. Pathology grade 1, 2, 3.
3. Paired frozen samples accessible.
| 2.0mm
| USBiolab
|
|
|
|
| € 283,00
|
| Stm150CS-02
| 1. stomach adenocarcinoma, 75 cases. Tumor and normal adjacent tissue. 2 cores/case.
2. 15 cases of clinical Stage I . 25 cases of stage II, 25 cass of stage III, 10 cases of stage IV.(all cases overlapped with Stm180-01)
| 1.5mm
| USBiolab
|
|
|
|
| € 476,00
|
| Bre01-003
| 1. Breast carcinoma (80 cases), 2 cores/case. Normal adjacent tissue (10 cases), 2 cores/case. Other carcinoma (20 cases), 1 core/case.
2. Pathology grade 1, 2, 3.
3. ER, PR information.
| 1.0mm
| USBiolab
|
|
|
|
| € 325,00
|
| Rec180Sur-04
| 1. Rectum adenocarcinoma (90 cases) with survival information, tumor ( 1 core/case) and matched normal adjacent tissue. Clinical stage I-IV (Version 7.0).
2. Surgery date 2007.10 - 2008.10, visit date 2012.8. Being followed up for 5-6 years.
| 1.5mm
| USBiolab
|
|
|
|
| € 1.130,00
|
| Stm02-004
| 1. Signet ring cell carcinoma (32 cases), 1 core/case.
2. Pathology grade 3.
| 2.0mm
| USBiolab
|
|
|
|
| € 156,00
|
| DS147-01
| 1. Colon adenocarcinoma (24 cases) and rectum adenocarcinoma (25 cases), tumor (1 core/case), matched normal adjacent tissue (1 core/case) and lymph nodes (1 core/case).
2. Clinical Stage N0 (12 cases), N1a (5 cases), N1b (5 cases), N2a (9 cases), N2b (
| 1.5mm
| USBiolab
|
|
|
|
| € 428,00
|
| DS075-01
| 1. Carcinoma of large intestine, 14 cases have primary tissue, normal adjacent tissue and metastasis tissue, 14 cases have primary tissue and metastasis tissue, 4 cases have metstasis tissue.
| 2.0mm
| USBiolab
|
|
|
|
| € 400,00
|
| Rec180Sur-05
| 1. Rectum adenocarcinoma (90 cases) with survival information, tumor ( 1 core/case) and matched normal adjacent tissue.
2. Clinical stage I-IV (Version 7.0).
3. Surgery date 2008.12?2009.12, visit date 2014.3. Being followed up for 4.3-5.3 years.
| 1.5mm
| USBiolab
|
|
|
|
| € 1.168,00
|
| Lug150PT-01
| 1. Non-small cell lung carcinoma (75 cases), containing adenocarcinoma (30 cases), squamous cell carcinoma (30 cases), bronchio alveolar carcinoma (5 cases), adenosquamous carcinoma (7 cases) and large cell carcinoma (3 cases).
2. Tumor (1 core/case) an
| 1.5mm
| USBiolab
|
|
|
|
| € 400,00
|
| Col060CS-01
| 1. Early colon adenocarcinoma, 30 cases. Tumor (1 core/case) and matched normal adjacent tissue (1 core/case). Wih clinical stage information (Version 7.0).
| 1.5mm
| USBiolab
|
|
|
|
| € 283,00
|
| Col180-01
| 1. Colon adenocarcinoma (90 cases), tumor and NAT.
2. 100% cases have TNM detail information. Clinical stage I-IV (Version7.0).
3. Pathology grade 1, 2, 3.
| 1.5mm
| USBiolab
|
|
|
|
| € 545,00
|
| Pro180-02
| 1. Prostate carcinoma(97 cases), 78 cases have tumor (1 core/case) and normal adjacent tissue (1 core/case). 19 cases have tumor (1 core/case). 5 cases have normal tissue.
2. Pathology grade and Gleason grade available.
| 1.5mm
| USBiolab
|
|
|
|
| € 695,00
|
| Stm030PT-01
| Various gastric diseaases, 1 core/case:normal gastric mucosa, gastric ulcer, gastric polyps and gastric intraepithelial neoplasia, gastric carcinoma/normal adjacent tissue
| 2.0mm
| USBiolab
|
|
|
|
| € 219,00
|
| Col180Sur-03
| 1. Colon adenocarcinoma (90 cases) with survival information, tumor (1 core/case) and matched normal adjacent tissue (1 core/case)
2. Clinical stage I-IV (Version7.0).
3. Surgery date 2008.4-2008.11, visit date 2012.8. Being followed up for 4.8-5.4 years
| 1.5mm
| USBiolab
|
|
|
|
| € 1.130,00
|
| Kid060CS-01
| 1.25 cases Renal clear cell carcinoma, tumor with matched normal adjacent tissue (or remote tissue/NAT/tumor)
2.Clinical stage(AJCC 7.0)I II III IV
3.5 cases of kidney cancer metastases
| 2.0mm
| USBiolab
|
|
|
|
| € 286,00
|
| Eso150-01
| 1. Esophagus squamous cell carcinoma (75 cases), tumor (1 core/case) and matched normal adjacent tissue (1 core/case).
2. Clinical stage I (11 cases), II (27 cases), III (27 cases), IV (10 cases).
3. 100% cases have TNM detail information.
4. Patho
| 1.5mm
| USBiolab
|
|
|
|
| € 545,00
|
| Col180Sur-02
| 1. Colon adenocarcinoma (93 cases) with survival information, 87 cases have tumor (1 core/case) and matched normal adjacent tissue (1 core/case), 6 cases have tumor tissue (1 core/case).
2. Clinical stage I-IV (Version7.0).
3. Surgery date 2007.5-2008.4
| 1.5mm
| USBiolab
|
|
|
|
| € 1.280,00
|
| Kid01-004
| 1. Kidney clear cell carcinoma (62 cases).
2. Tumor (2 cores/case) and matched normal adjacent tissue (2 cores/case).
| 1.0mm
| USBiolab
|
|
|
|
| € 325,00
|
| Liv030PG-01
| 1. Hepatocellular carcinoma (15 cases), tumor (1 cores/case) and matched normal adjacent tissue (1 cores/case).
2. Pathology grade 1, 2, 3.
| 2.0mm
| USBiolab
|
|
|
|
| € 156,00
|
| Liv180Sur-03
| 1. Hepatocellular carcinoma (90 cases). Tumor (1 core/case) and NAT (1 core/case).
2. Survival Information available.
3. Surgery date 2010.1-2011.9. Visit date 2013.9. Being followed up for 2-3.7 years.
| 1.5mm
| USBiolab
|
|
|
|
| € 1.280,00
|
| LivT10-205
| 1. Liver disease (20 cases), containing hepatocellular carcinoma (9 cases), cholangiocellular carcinoma (2 cases), hepatic adenoma (1 case), cirrhosis (3 cases) and hepatic hemangioma (5 cases).
2. Biochemical indicator available (AFP,HBV,HCV RNA).
| 2.0mm
| USBiolab
|
|
|
|
| € 241,00
|
| Stm180Sur-02
| 1. Gastric adenocarcinoma (90 cases) with survival information.
2. Tumor (1 core/case) and matched normal adjacent tissue (1 core/case).
3. Clinical stage I-IV (Version 7.0).
4. Being followed up for 5-5.5 years. VEGF and survivin information availab
| 1.5mm
| USBiolab
|
|
|
|
| € 1.133,00
|
| Gal100-01
| 1. Gallbladder carcinoma, 80 cases.
2. 20 cases have tumor and normal adjacent tissue. 60 cases have only tumor.
3. Survival information available.
| 1.5mm
| USBiolab
|
|
|
|
| € 545,00
|
| Pro162-02
| 1. Prostate cancer, intraepithelial neoplasia, normal gland, 80 cases, 2 cores/case.
2. Pre-operationi PSA, Gleason Score, ECT, capsular invasion information available.
| 1.5mm
| USBiolab
|
|
|
|
| € 695,00
|
| Stm01-007
| 1. Gastric carcinoma (110 cases), containing gastric carcinoma (83 cases) and esophagogastric junction carcinoma (27 cases).
2. Normal adjacent tissue (20 cases), containing adjacent normal mucosa tissue (10 cases), chronic gastritis (10 cases). 3 cores/
| 1.0mm
| USBiolab
|
|
|
|
| € 475,00
|
| MorgF090-01
| 1. Multiple organ (24 types) normal tissue array. 2-6 cases /organ, 1 core /case.
2. Thyroid, tongue, esophagus, stomach, duodenum, jejunum, ileum, appendix, colon, rectum, liver, pancreas, trachea, lung, myocardial, artery, skeletal muscle, skin, prost
| 2.0mm
| USBiolab
|
|
|
|
| € 503,00
|
| Stm02-001
| 1. Gastric adenocarcinoma (32 casee), 1 core/case.
2. Pathology grade 1, 1-2
| 2.0mm
| USBiolab
|
|
|
|
| € 156,00
|
| LugA030PG-01
| 1. Lung adenocarcinoma (15 cases), Tumor (1 core/case) and matched normal adjacent tissue (1 core/case).
2. Pathology grade 2,3.
| 2.0mm
| USBiolab
|
|
|
|
| € 197,00
|
| Eso01-004
| 1. Esophagus squamous cell carcinoma (92 cases), tumor (1 core/case) and matched normal adjacent tissue (1 core/case).
2. Clinical stage I-IV (Version 7.0).
3. 60% cases have TNM detail information.
4. Pathology grade 1, 2, 3.
| 1.5mm
| USBiolab
|
|
|
|
| € 475,00
|
| Kid03-002
| 1. Kidney clear cell carcinoma (31 cases), tumor (1 core/case) and matched normal adjacent tissue (1 core/case).
2. Pathology grade 1.
| 2.0mm
| USBiolab
|
|
|
|
| € 241,00
|
| Col180Sur-07
| 1. Colon adenocarcinoma (90 cases) with survival information, tumor(1 core/case) and matched normal adjacent tissue (1 core/case).
2. Clinical stage I-IV (Version7.0).
3. Surgery date 2009.1-2009.10, visit date 2014.5. Being followed up for 4.6-5.3 yea
| 1.5mm
| USBiolab
|
|
|
|
| € 1.207,00
|
| Bre140Sur-02
| 1. Breast cancer 140 cases. 1 core/case.
2. Clinical Stage I, II, III (Version 6.0).
3. Surgery date 2004.8?2008.12, visit date 2014.7 . Being followed up for 5.6~10 years.
4. 140 cases overlaped with Bre150Sur-02
| 1.5mm
| USBiolab
|
|
|
|
| € 1.243,00
|
| Liv02-001
| 1. Hepatocellular carcinoma (32 cases), 1 core/case.
2. Pathology grade 1, 1-2.
| 2.0mm
| USBiolab
|
|
|
|
| € 156,00
|
| Bre060-01
| 1. Breast carcinoma (30 cases), mainly invasive ductal carcinoma.
2. Tumor (1 core/case) and matched normal adjacent tissue (1 core/case).
3. Clinical stage 0, I, II, III (Version 6.0).
4. 100% cases have TNM detail information.
5. Pathology grade 1,
| 2.0mm
| USBiolab
|
|
|
|
| € 255,00
|
